Evernorth Specialty Management

Solutions

New Tests and Therapies Enable Personalized Cancer Treatment

Oncology is one of the most complex areas of medical care. Evernorth’s clinical consult program pairs subspecialists from leading cancer centers with community oncologists, improving access to the bes...

April 13, 23

Innovation in hemophilia drug development and cost-efficiency tools

As treatment for hemophilia evolves, data proves a good specialty pharmacy partner can help minimize waste and drive efficient practices.

Lesley D'Albini, PharmD, May 24, 23

Three specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs

Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...

Harold Carter, April 20, 22

Simplifying Medical Benefit Drug Management Complexities

An integrated approach to managing medically billed specialty drugs is key to optimizing cost savings and clinical outcomes.

Mark Bini, July 20, 22

Two Ways to Assess the Holistic Value of Your Specialty Partner

Getting the most value out of your specialty drug management partner starts with asking the right questions.

Stephanie Uder, October 06, 22

Copay Assistance Strategy Reduces Financial Burdens for Plans And Patients

Innovative solution provides $0 member cost for costly specialty drugs while reducing plans’ costs

Meghan Pasicznyk, PharmD, October 07, 21

Biosimilar Approval and Adoption Challenges

Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.

Harold Carter, June 10, 22